139 related articles for article (PubMed ID: 16858126)
1. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
2. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
Fetih G; Habib F; Okada N; Fujita T; Attia M; Yamamoto A
J Control Release; 2005 Sep; 106(3):287-97. PubMed ID: 15982776
[TBL] [Abstract][Full Text] [Related]
4. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the influence of nitric oxide donors on intestinal absorption of macromolecules.
Takahashi K; Numata N; Kinoshita N; Utoguchi N; Mayumi T; Mizuno N
Int J Pharm; 2004 Nov; 286(1-2):89-97. PubMed ID: 15501005
[TBL] [Abstract][Full Text] [Related]
6. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
7. Improvement of intestinal absorption of macromolecules by nitric oxide donor.
Numata N; Takahashi K; Mizuno N; Utoguchi N; Watanabe Y; Matsumoto M; Mayumi T
J Pharm Sci; 2000 Oct; 89(10):1296-304. PubMed ID: 10980504
[TBL] [Abstract][Full Text] [Related]
8. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
Morishita M; Morishita I; Takayama K; Machida Y; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):68-72. PubMed ID: 7690292
[TBL] [Abstract][Full Text] [Related]
9. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
11. [Improvement of intestinal absorption of poorly absorbable drugs by polyamidoamine (PAMAM) dendrimers as novel absorption enhancers].
Yamamoto A
Yakugaku Zasshi; 2010 Sep; 130(9):1123-7. PubMed ID: 20823669
[TBL] [Abstract][Full Text] [Related]
12. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
[TBL] [Abstract][Full Text] [Related]
14. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
[TBL] [Abstract][Full Text] [Related]
16. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat.
Yan C; Gu J; Lv Y; Shi W; Jing H
Drug Deliv Transl Res; 2017 Jun; 7(3):408-415. PubMed ID: 28303451
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of reversible absorption-enhancing effect of sodium nitroprusside in rat small intestine.
Takizawa Y; Kishimoto H; Kitazato T; Ishizaka H; Kamiya N; Ito Y; Tomita M; Hayashi M
Eur J Pharm Sci; 2013 Jul; 49(4):664-70. PubMed ID: 23707468
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
19. Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids.
Miyake M; Minami T; Hirota M; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Control Release; 2006 Mar; 111(1-2):27-34. PubMed ID: 16410031
[TBL] [Abstract][Full Text] [Related]
20. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
